Bovilis Piliguard Pinkeye

Moraxella Bovis Bacterin

This product has been shown effective for the vaccination of healthy cattle against Moraxella bovis. This product was licensed prior to the requirement to establish minimum age for use. Duration of immunity has not been established. For more information regarding efficacy and safety data, go to productdata.aphis.usda.gov.

ADMINISTRATION: The vaccine may be warmed to room temperature prior to injection. Shake well and using aseptic technique inject 2.0 mL dose intramuscularly or subcutaneously into the neck 3-6 weeks prior to onset of pinkeye season. Historically, annual revaccination with this product has been recommended. The need for this booster has not been established. For more information on revaccination frequency, consult your veterinarian.

Bovilis Piliguard Pinkeye Caution

Store at 2°-8°C (35°-46°F). Do not freeze. Use entire contents when first opened. Do not mix with other products. Do not vaccinate within 60 days before slaughter. Use may occasionally lead to development of granulomas which may persist for several weeks. Transient local reaction may occur at the injection site. This product has not been tested in pregnant animals. If allergic reaction occurs, treat with epinephrine. Extreme caution should be used with any oil emulsion vaccine; avoid injecting your own finger or hand. Accidental injection can cause serious local reaction. In case of human exposure, contact a physician. Contains Gentamicin and Formaldehyde as preservatives.

FOR ANIMAL USE ONLY

Intervet Inc., d/b/a Merck Animal Health, Omaha, NE 68103 USA

VLN 165A/PCN 2772.03

1 800 521-5767

For patent information: http://www.merck.com/product/patent/home.html

CPN: 1047153.6